Pharmaceutical Development and Technology

Transcription

1 Tentative Agenda conferenceseries.com Media Partners 2 nd International Conference and Exhibition on Pharmaceutical Development and Technology Collaborators May 11-12, 2018 Osaka, Japan B2B Participation Interactive Sessions Keynote Lectures Plenary Lectures Workshops Exhibitors Meetings

2 Invitation... Dear Colleagues, Conference Series LLC extends its welcome to 2 nd International Conference and Exhibition on Pharmaceutical Development and Technology May 11-12, 2018 at Osaka, Japan. Conference Series LLC organizes a conference series of Global Events with over Conferences, Symposiums and Workshops in USA, Europe, Middle East & Asiapacific with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over eminent personalities, reputed scientists as editorial board members. Theme of the conference, Future Trends in the Development of Pharmaceuticals is designed in such a way to uncover the basic principles that lead to the drastic emergence and technologies in the field of Pharmaceutical Development and Technology. We hope Pharmatech 2018 is the best platform to discuss the basic principles involved in the development of Pharmaceutical technology and Development. As this conference deals with the basics concepts, students, delegates, academicians and business people can attend the conference to root up the knowledge and excel in this field. Conference will focus on the following topics during presentations of the two day event, which reflect current education research, developments and innovations internationally and as evidenced in Pharmaceutical technology and Development. Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management

3 Organizing Committee Members Julian Fincher University of South Carolina USA Ajaz S. Hussain The National Institute for Pharmaceutical Technology and Education, US Naeem Hasan Khan Quest International University Malaysia Weiguo Dai Johnson & Johnson USA Joseph P. Fuhr Jr University of Sciences USA Ben Ajepe B.Perazim Pharmaceutical Ltd Nigeria Maha Aboul Ela Beirut Arab University Lebanon Saeed Qureshi Universiteit Gent Ottawa, Canada Ying Li Nanjing Medical University China Dr. Rezaee Research Institute of Forests and Rangelands, Iran S. K. SINGH Diamond Pharma and Research, India Thomas Wirth Cardiff University UK Makarand Jawadekar University of Minnesota-Twin Cities, London

4 Tentative Agenda May 11, 2018 Time 08:30-09:30 09:30-11:30 Session Registrations Keynote Forum 11:30-11:45 11:45-12:45 Network & Refreshments Break* Track 1: Pharmaceutics & Biopharmaceutics Track 2: Drug Targeting & Drug Development Lunch Break** Track 3: Pharmaceutical Research Track 4: Pharmaceutical Materials Track 5: Pharmaceutical Formulations Network & Refreshments Break* Track 6: Pharmaceutical Biotechnology Track 7: Pharmaceutical Nanotechnology 12:45-13:30 13:45-14:30 14:30-15:15 15:15-16:00 16:00-16:30 16:30-17:15 17:15-18:00 May 12, 2018 Time 08:30-09:30 09:30-10:30 10:30-11:30 11:30-11:45 11:45-13:00 13:00-13:45 13:45-16:00 16:00-16:30 16:30-17:15 17:15-18:00 Session Keynote Forum Track 8: Pharmaceutical Technology Track 9: Pharmaceutical Manufacturing Network & Refreshments Break* Track 10: Pharmaceutical Engineering Track 11: Drug Delivery Technologies Lunch Break** Track 12: Medical Devices Track 13: Drug Regulatory Affairs Network & Refreshments Break* Track 14: Pharmaceutical Management Poster Presentation Group Photo Day Concludes Day Concludes * Exclusive Exhibitor Event ** Networking Event Note: Conference schedule is subject to change. Note: Workshops and Symposia slots are available. To book slot for Workshop and Symposium send us the proposal.

5 Day 1 11 th May 2018 Registrations Introduction Opening ceremony **Speaker Slots Available** Combination sirna/drug nanopreparations for multidrug resistant cancer Vladimir P Torchilin, Northeastern University,USA Smart Soft Matter Enabled Nanomedicines Michael Whittaker, ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Australia Development and Bio-applications of Nontoxic C-Dots Roger M. Leblanc,University of Miami, USA Modes of Topical and Localized Drug Delivery of Nanoparticle and Microparticle Based Formulations Irach B Taraporewala, Sitara Pharmaceutical Group, New York, USA The scientific basis of defining quality pharmaceutical products and their assessment Saeed Qureshi, PharmacoMechanics, Canada Antibacterial Activity of Tetrazole Derivatives Adiel Coca, Southern Connecticut State University, USA Development of Commercial-Ready Processes for Antibody Drug Conjugates Xi Hu, Pfizer, USA Laser triggered release of gemcitabine from polymer coated gold nanoshells for pancreatic cancer Mina Emamzadeh, UCL School of Pharmacy, UK Enhancement Of The Release Of Curcumin By Freeze Drying Technique Using Inulin And Neusilin As Carriers Mai Khanfar, Jordan University of Science and Technology, Jordan Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies Ying Li, Nanjing Medical University, China Higher Priced Older Pharmaceuticals: How Should We Respond? Richard S.Irwin, University of Massachusetts Medical School, USA Linear and Branched Polyethynimines for skin regeneration treatment In vitro study Lucas B Naves, University of Minho, Portugal Active methodology and blended learning: An experience in pharmaceutical care Lawrence X Yu, Food and Drug Administration, USA Antiangiogenic and AMP-Activated Protein Kinase Activities of Gracilaria coronopifolia J.G. Agardh Extracts Katrin Mae M. Ortega, University of Santo Tomas, Philippines Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development StefanSeeger, Business Chemistry Group, Switzerland Confirmed Speakers

6 Day 2 12 th May 2018 Introduction Opening ceremony **Speaker Slots Available** Association between HLA-B15:02 and Oxcarbazepine induced cutaneous adverse reaction: a meta-analysis Xiaoling Wang, Capital Medical University, China Fluorometholone loaded nanospheres PLGA for the treatment of oculars disorders Roberto González Pizarro, University of Barcelona, Spain Encapsulation of agonist PPAR- γ in polymeric nanoparticles to treat ocular inflammatory processes Marcelle Silva de Abreu, University of Barcelona, Spain Phytotherapeutic Investigation of Selected Lebanese Medicinal Plants Maha Aboul-Ela, Beirut Arab University, Lebanon Effects of some lactobacillus strains on plasma lipids of rats and fecal microflora. Ahmed R Awd, Egypt "Identification of Bifidobacterium Animalis Ssp. Lactis from Egyptian Women Breast Milk and Feces of Breast Fed Infant Based on Molecular Level" Ali M Awaad, Egypt High-speed electrospinning of aqueous polymer solutions for the solid formulation of biopharmaceuticals Edit Hirsch, Budapest University of Technology and Economics, Hungary A Review on Indoor air purifier plants Rashmi Saxena Pal, Kanpur,India Technology Development of Bi/Multilayer Thin Films Nidhi P. Sapkal, Zim Laboratories Ltd, India Personalized Medication Parag A. Kulkarni, NMIMS, India Amberlite IR-120 (H) mediated on water synthesis of anticancer Ruthenium (II)-arene 8-hydroxyquinoline complexes Sourav De, VIT University, India Drug printed Oral Thin Films: Future trend in drug delivery technology Vaishali Kilor, Gurunanak College of Pharmacy, India

7 Glimpses of past conference

8 Tourist Attractions

9 Venue Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka has also been known as the Nation s Kitchen. With a population of 2.5 million, Osaka is Japan s third largest and second most important city. It has been the economic powerhouse of the Kansai region for many centuries. The city s west side has the main port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky building and the Tempozan Harbour Village. Osaka is known for its food, both in Japan and abroad. Author Michael Booth and food critic François Simon of Le Figaro have both suggested that Osaka is the food capital of the world. Osaka s culinary prevalence is the result of a location that has provided access to high quality ingredients, a high population of merchants, and close proximity to the ocean and waterway trade. In recent years, Osaka has started to garner more attention from foreigners with the increased popularity of cooking and dining in popular culture. The National Museum of Art (NMAO) is a subterranean Japanese and international art museum, housing mainly collections from the post-war era and regularly welcoming temporary exhibitions. Osaka Science Museum is in a five storied building next to the National Museum of Art, with a planetarium and an OMNIMAX theatre. You ll fall in love with Japan Venue: Hyatt Regency Osaka Chome Nankokita, Suminoe Ward, Osaka, Osaka Prefecture , Japan Mail us to know more! For Abstract Submission Guidelines For Reserving your slot Proposals Registration Posters Accommodations No doubt you have lots of queries... Why not get in touch..! Drop us your query with details and we will call you right away For Queries Contact: Alex Tata Program Manager pharmatech@pharmaceuticalconferences.org Office Ph: Ext: 6094 Toll No: (USA & Canada) For Exhibition & Sponsorship Contact: Alex Tata pharmatech@pharmaceuticalconferences.org Hosted by Conference Series Ltd. 57 Ullswater Avenue, West End Southampton, Hampshire United Kingdom, SO 183QS Toll Free: pharmatech@pharmaceuticalconferences.org